India Enters "Pay-for-Delay" Fray: CCI Investigating Pharmaceutical Patent Settlements
By EsqSocial Corporation 13/08/14
India's competition authority, the Competition Commission of India (CCI), has begun scrutinizing and investigating pharmaceutical patent settlement agreements between brand and generic firms for potential anticompetitive effects. It has been reported...
By: Wilson Sonsini Goodrich & Rosati